Friday, November 19, 2010

Darvon and Darvocet get pulled from the market

FDA Says Xanodyne Agrees To Withdraw Propoxyphene From U.S. Market. This means that Darvon and Darvocet will be getting pulled from the market. 

Xanodyne Pharmaceuticals Inc. which makes Darvon and Darvocet, the brand version of the prescription pain medication propoxyphene, has agreed to withdraw the medication from the U.S. market at the request of the U.S. Food and Drug Administration. The FDA has also informed the generic manufacturers of propoxyphene-containing products of Xanodyne’s decision and requested that they voluntarily remove their products as well.

The FDA sought market withdrawal of propoxyphene after receiving new clinical data showing that the drug puts patients at risk of potentially serious or even fatal heart rhythm abnormalities. As a result of these data, combined with other information, including new epidemiological data, the agency concluded that the risks of the medication outweigh the benefits.

Read more on the FDA website.

No comments:

Post a Comment

Blog Widget by LinkWithin